Searched for
SANOFI STOCK
Dividend alert! Last day to buy HDFC Bank, Tata Motors PV, 14 other stocks for dividends worth Rs 248Under SEBI's T+1 settlement cycle, investors must purchase a company's shares at least one trading day before the record date to ensure the...
Inside Cursor's journey to a $60 billion deal with Elon Musk’s SpaceXSpaceX has acquired AI coding assistant Cursor for $60 billion in an all-stock deal, significantly bolstering its AI ambitions. This move p...
Dividends and bonus issues: 31 stocks turning ex-record date this week. Do you own any?As many as 31 companies, including HDFC Bank, Tata group firms and Brigade Enterprises, will turn ex-record date for dividends and bonus is...
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
Bonus issue, stock split, dividend: 9 stocks to turn ex-record date next week, check detailsRail Vikas Nigam Limited shares rose 6% after securing a ₹967 crore railway order, strengthening its order book and boosting investor senti...
Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
Sanofi India board OKs demerger of consumer health businessDrug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. Th...
Hold Sanofi India, target price Rs 6270: ICICI DirectSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals s...
Buy Sanofi India, target price Rs 9250: Sharekhan by BNP ParibasSanofi reported strong results for Q1CY22 with operating margins expanding 139 bps y-o-y and were better than estimated, leading to a PAT a...
Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
Sanofi's valuations are attractive: Why it is stock pick of weekSanofi India’s management has adopted cost control measures and has lowered promotional spends, which was visible in 2020. Its digital push...
Sanofi India shares hit 52-week high on Q4 resultsThe stock witnessed similar movement on the NSE as well, where it opened at 7,549.95.
Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
Sanofi India stock likely to be re-rated on company's improving fundamentalsHowever, unlike other multinational pharmaceutical companies, Sanofi India was not analysts’ favourite for quite some time.
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: Report
French drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...
- Sun's EPS may take a knock if it stops cancer drug sale
The stock of Sun Pharma fell for a fourth day in a row, as investors are worried about the company's legal tussle with Sanofi-Aventis over ...
- Sanofi-Aventis revises open offer for Aventis Pharma
The schedule of Sanofi-Aventis' open offer for shareholders of Aventis Pharma Ltd has been revised by DSP Merrill Lynch, manager of the off...